Showing results (731-740 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|October 27, 2022
Trastuzumab and pertuzumab without chemotherapy in early-stage HER2+ breast cancer: a plain language summary of the PHERGain studyJosé Manuel Pérez-García, Geraldine Gebhart, Manuel Ruiz Borrego, et al.
Future Oncology (London, England)|November 4, 2022
Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in JapanShinsuke Iida, Mayuko Nakakoji, Dionysis Spanopoulos, et al.
Future Oncology (London, England)|October 13, 2022
Does race make a difference in how long men with advanced prostate cancer live when treated with abiraterone or enzalutamide?Daniel J George, Krishnan Ramaswamy, Ahong Huang, et al.
Future Oncology (London, England)|November 1, 2022
Effect of lateral lymph nodes without malignant characteristics on the prognosis of patients with rectal cancerChenghai Zhang, Ming Cui, Jiadi Xing, et al.
Future Oncology (London, England)|September 14, 2022
Systematic literature review of efficacy and safety of first-line maintenance therapy trials in advanced ovarian cancerHolly Guy, Carol Hawkes, Lydia Walder, et al.
Future Oncology (London, England)|October 5, 2022
Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamideVincent M Bivins, Mike Durkin, Ibrahim Khilfeh, et al.
Future Oncology (London, England)|October 6, 2022
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomesGiovanni Grignani, Axel Le Cesne, Javier Martín-Broto
Future Oncology (London, England)|September 2, 2022
A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncologyOlivier Chassany, Anke van Engen, Livia Lai, et al.
Future Oncology (London, England)|August 30, 2022
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT TurkeyAhmet Özet, Faysal Dane, Nuri Faruk Aykan, et al.
Future Oncology (London, England)|September 1, 2022
Bladder cancer diagnosis with a four-miRNA panel in serumXinji Li, Wenkang Chen, Rongkang Li, et al.
Pageof 452